SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
Shockwave’s first-of-its-kind technology is now available on two platforms: a Forward IVL platform and a Balloon IVL platform ...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the ...
Medical device manufacturer Shockwave Medical is set to acquire Canada-based cardiovascular device manufacturer Neovasc for $75 million. Shockwave will purchase outstanding Neovasc shares for $27.25 ...
Shockwave’s R&D team meet with CEO Doug Godshall (seated, center) weekly to assess the progress of current projects and pitch new ideas. BY FastCo Works Cardiologists have long been confounded by a ...
(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...
As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...
DUBLIN, Dec. 18, 2020 /PRNewswire/ -- The "Extracorporeal Shockwave Device Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application" report has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback